Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Hikma Pharmaceuticals PLC (GB:HIK)
LSE:HIK
Hikma Pharmaceuticals (HIK) Share Price & Analysis
10 Followers
HIK Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range1,153.82p - 1,915.50p
Previous Close1,803p
Volume20.39K
Average Volume (3M)547.15K
Market Cap
£3.98B
Enterprise Value479.01B
Total Cash (Recent Filing)$292.00M
Total Debt (Recent Filing)$1.28B
Price to Earnings (P/E)26.5
Beta0.74
Next Earnings
Aug 03, 2023EPS Estimate
£0.76Last Dividend Ex-Date
Mar 23, 2023Dividend Yield
0.42 (0.02%)Share Statistics
EPS (TTM)0.65
Shares Outstanding220,235,852
10 Day Avg. Volume515,666
30 Day Avg. Volume547,154
Standard Deviation0.11
R-Squared0.00655
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)390.26
Price to Sales (P/S)431.29
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit386.92
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
1,993.75pPrice Target Upside10.49% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
HIK FAQ
What was Hikma Pharmaceuticals PLC’s price range in the past 12 months?
Hikma Pharmaceuticals PLC lowest share price was 1153.82p and its highest was 1915.50p in the past 12 months.
What is Hikma Pharmaceuticals PLC’s market cap?
Currently, no data Available
When is Hikma Pharmaceuticals PLC’s upcoming earnings report date?
Hikma Pharmaceuticals PLC’s upcoming earnings report date is Aug 03, 2023 which is in 60 days.
How were Hikma Pharmaceuticals PLC’s earnings last quarter?
Hikma Pharmaceuticals PLC released its earnings results on Feb 23, 2023. The company reported 0.708p earnings per share for the quarter, beating the consensus estimate of 0.622p by 0.085p.
Is Hikma Pharmaceuticals PLC overvalued?
According to Wall Street analysts Hikma Pharmaceuticals PLC’s price is currently Undervalued.
Does Hikma Pharmaceuticals PLC pay dividends?
Hikma Pharmaceuticals PLC pays a Annually dividend of 30.77p which represents an annual dividend yield of 2.54%. See more information on Hikma Pharmaceuticals PLC dividends here
What is Hikma Pharmaceuticals PLC’s EPS estimate?
Hikma Pharmaceuticals PLC’s EPS estimate is £0.76.
How many shares outstanding does Hikma Pharmaceuticals PLC have?
Hikma Pharmaceuticals PLC has 220,988,500 shares outstanding.
What happened to Hikma Pharmaceuticals PLC’s price movement after its last earnings report?
Hikma Pharmaceuticals PLC reported an EPS of 0.708p in its last earnings report, beating expectations of 0.622p. Following the earnings report the stock price went down -2.025%.
Which hedge fund is a major shareholder of Hikma Pharmaceuticals PLC?
Currently, no hedge funds are holding shares in GB:HIK
---
Hikma Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
1,993.75p (10.49% Upside)
1,993.75p (10.49% Upside)
Insider Transactions
Sold Shares
Worth £463.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.87%
12-Months-Change
Fundamentals
Return on Equity
8.16%
Trailing 12-Months
Asset Growth
15.15%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Hikma Pharmaceuticals PLC
Founded in the Middle East and with headquarters in London, Hikma manufactures generic and in-licensed pharmaceuticals. The firm operates in three segments: injectables, generics, branded, and other, which comprise most of the company's revenue at about 41%, 33%, and 26%, respectively. About 62%, 33%, and 6% of Hikma's sales are based in the U.S., Middle East, North Africa, and Europe, and Other.
---
Top 5 ETFs holding HIK
iShares MSCI United Kingdom ETF
$4.77M
UBS (Irl) ETF Plc - MSCI United Kingdom IMI Socially Responsible UCITS ETF EUR
$3.61M
UBS (Irl) ETF Plc-MSCI United Kingdom IMI Socially Responsible CHF
$3.61M
UBS ETF MSCI UK Shs -A- Distribution
$3.02M
UBS (Lux) Fund Solutions SICAV - MSCI United Kingdom UCITS ETF A- Capitalisation
$2.94M
Up to five ETFs with an Outperform Smart Score that hold HIK. The ETFs are listed according to market value of HIK within the ETF
---
---